Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei (2022)
Fonte: Journal of surgical research. Unidade: FM
Assuntos: NEOPLASIAS PERITONEAIS, PROGNÓSTICO, BIOMARCADORES
ABNT
LOPES, Andre et al. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. Journal of surgical research, v. 274, p. 68-76, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jss.2022.01.001. Acesso em: 10 out. 2024.APA
Lopes, A., Mello, E. S. de, Lopez, R. V. M., Leonardi, P. C., & Ribeiro Junior, U. (2022). Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. Journal of surgical research, 274, 68-76. doi:10.1016/j.jss.2022.01.001NLM
Lopes A, Mello ES de, Lopez RVM, Leonardi PC, Ribeiro Junior U. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei [Internet]. Journal of surgical research. 2022 ; 274 68-76.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/j.jss.2022.01.001Vancouver
Lopes A, Mello ES de, Lopez RVM, Leonardi PC, Ribeiro Junior U. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei [Internet]. Journal of surgical research. 2022 ; 274 68-76.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/j.jss.2022.01.001